The Amyloidosis Channel is supported with funding from Prothena (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Looking forward to ISA 2022
In this video, Joan Bladé, MD, PhD, University of Barcelona, Barcelona, Spain, discusses the upcoming meeting of the International Society of Amyloidosis (ISA) being held in Heidelberg on September 4-8, 2022. Prof Bladé briefly discusses previous ISA meetings and further emphasizes the importance of these meetings as an educational platform for amyloidosis. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
Disclosures
Honoraria for lectures: Janssen, BMS, Amgen, Takeda, Oncopeptides
